BNTX – biontech se - american depositary shares (US:NASDAQ)
Stock Stats
News
11/19
07:30 am
bntx
Low
BioNTech SE (NASDAQ: BNTX) is now covered by analysts at Berenberg Bank. They set a "buy" rating and a $130.00 price target on the stock.
11/19
07:30 am
bntx
Low
BioNTech SE (NASDAQ: BNTX) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $125.00 price target on the stock, up previously from $110.00.
11/18
08:09 am
bntx
Low
BioNTech SE (NASDAQ: BNTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $150.00 price target on the stock.
11/14
11:23 am
bntx
Medium
BioNTech SE (NASDAQ: BNTX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $171.00 price target on the stock.
11/13
06:45 am
bntx
Medium
BioNTech to Acquire Biotheus to Boost Oncology Strategy
11/4/2024
06:45 am
bntx
-3.1%
BEAT
8/5/2024
05:59 am
bntx
-0.4%
MISS
5/6/2024
06:45 am
bntx
0.3%
MISS
3/20/2024
06:15 am
bntx
-3.1%
MISS
11/19
07:30 am
Initiates
Buy
Berenberg Bank
Low
2.3%
11/19
07:30 am
Initiates
Buy
Berenberg Bank
Low
2.3%
11/19
07:30 am
Upgrades
In-Line
Outperform
Evercore ISI
Low
2.3%
11/19
07:30 am
Upgrades
In-Line
Outperform
Evercore ISI
Low
2.3%
11/19
07:22 am
Upgrades
In-Line
Outperform
Evercore ISI Group
Low
2.7%
11/15
05:13 pm
bntx
Medium
Form 144 BioNTech SE Filed by: Jeggle Helmut Wolfgang
11/14
07:39 am
bntx
Medium
Form 6-K BioNTech SE For: Nov 14
11/13
06:50 am
bntx
Medium
Form 6-K BioNTech SE For: Nov 13
11/12
09:25 am
bntx
Low
Form 144 BioNTech SE Filed by: Tureci Ozlem
11/4
06:57 am
bntx
Medium
Form 6-K BioNTech SE For: Sep 30
Show more
Top News Gainers
3/17 Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine 57.1%
3/18 BioNTech (BNTX) Skyrockets on Coronavirus Vaccine Hopes; One Analyst Remains Cautious [Yahoo! Finance News] 30.5%
4/22 Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2020 - ResearchAndMarkets.com 26.6%
3/16 BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat 25.1%
11/4 BioNTech SE (NASDAQ: BNTX) is now covered by analysts at Bank of America Corp. They set a "buy" rating and a $21.00 price target on the stock. 12.2%
1/3 Global Novel Vaccine Delivery Devices Industry Report 2019-2030 10.6%
2/3 BioNTech Announces Commencement of Public Offering of American Depositary Shares 9.7%
1/6 Genevant Sciences to Present at Biotech Showcase 2020 9.4%
3/26 Detailed Insights into In Silico/Computer-Aided Drug Discovery Services Market to 2030 - Elaborate Profiles of Key Industry Players - ResearchAndMarkets.com 8.6%
12/6 Precision Medicine Market: Industry Analysis and Detailed Profiles of Neon Therapeutics, Moderna, Inc, Merck & Co., Inc, Bayer AG, PERSONALIS INC, GENOCEA BIOSCIENCES, INC | Data Bridge Market Research 8.4%
Top News Decliners
3/18 German Billionaire Twins’ Investment In Biotech Firm Surges After Deal With Pfizer On Coronavirus Vaccine [Forbes] -35.5%
3/19 Search for Coronavirus Vaccine Becomes a Global Competition [The New York Times] -23.1%
10/23 Global Personalized Cancer Vaccine Market, Clinical Trials & Future Outlook 2026 - ResearchAndMarkets.com -17.3%
4/22 Form 6-K BioNTech SE For: Apr 22 -15.7%
4/6 BioNTech SE (NASDAQ: BNTX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $59.00 price target on the stock. -15.6%
4/23 Pfizer Targets Summer For COVID-19 Vaccine Human Trials; Potential Treatment Also In The Works. [The Motley Fool] -14.1%
10/10 BioNTech Announces Pricing of Initial Public Offering -13.7%
3/16 BioNTech up 55% premarket on advancement of coronavirus vaccine [Seeking Alpha] -13.4%
4/9 Global Pharma, Biotech & Diagnostics Co-promotion & Co-marketing Partnering Terms & Agreements Report, 2014-2020 -11.7%
1/16 BioNTech to acquire Neon to strengthen global leadership position in T cell therapies -11.6%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3